Structure of a DNA−Bisdaunomycin Complex,
- 1 May 1997
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 36 (20) , 5940-5946
- https://doi.org/10.1021/bi9705218
Abstract
The application of detailed structural data bases has now culminated in the successful design of a new generation of bisanthracyclines that form ultratight DNA complexes [Chaires, J. B., Leng, F., Przewloka, T., Fokt, I., Ling, Y. H., Perez-Soler, R., & Priebe, W. (1997) J. Med. Chem. 40, 261-266]. Daunomycin dimers were designed to bind to DNA in complexes resembling those of monomers intercalated at adjacent sites. The goal of the work described here was to determine, with X-ray crystallography, if a potent member of this newly designed and synthesized class of bisanthracyclines (WP631) binds as intended. WP631 is composed of two daunomycin molecules, linked N3' to N3' by a xylyl group. We have solved the 2.2 A X-ray crystal structure of a complex of WP631 bound to [d(CGATCG)]2. We demonstrate, on a detailed molecular level, that the WP631 design strategy is a success. The structures of WP631 and two daunomycin molecules bound to [d(CGATCG)]2 provide the unprecedented opportunity for detailed comparison of mono- and bis-intercalated complexes of the same chromophore, allowing us to distinguish effects of mono-intercalation from those of bis-intercalation. Differences are focused primarily in the centers of the complexes. DNA unwinding and other helical distortions propagate more efficiently to the center of the WP631 complex than to the center of the daunomycin complex.Keywords
This publication has 8 references indexed in Scilit:
- Structure-Based Design of a New Bisintercalating Anthracycline AntibioticJournal of Medicinal Chemistry, 1997
- Bisimidazoacridones and Related Compounds: New Antineoplastic Agents with High Selectivity against Colon TumorsJournal of Medicinal Chemistry, 1995
- Anthracycline binding to DNAEuropean Journal of Biochemistry, 1992
- Structure of 11-deoxydaunomycin bound to DNA containing a phosphorothioateJournal of Molecular Biology, 1990
- Preferential binding of daunomycin to 5'TACG and 5'TAGC sequences revealed by footprinting titration experimentsBiochemistry, 1990
- Molecular Mechanisms of Specificity in DNA–Antitumour Drug InteractionsPublished by Elsevier ,1989
- The interaction of adriamycin and adriamycin analogues with nucleic acids in the B and A conformationsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1979
- Nucleic acid binding drugs. Part IV. The crystal structure of the anti-cancer agent daunomycinBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1977